MedEquities Realty Trust Inc (NYSE:MRT) – Stock analysts at KeyCorp lifted their Q4 2017 EPS estimates for MedEquities Realty Trust in a note issued to investors on Thursday. KeyCorp analyst J. Sadler now forecasts that the financial services provider will earn $0.31 per share for the quarter, up from their prior estimate of $0.29. KeyCorp has a “Buy” rating and a $13.00 price objective on the stock. KeyCorp also issued estimates for MedEquities Realty Trust’s FY2018 earnings at $1.18 EPS.

Several other brokerages also recently commented on MRT. B. Riley restated a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 1st. Capital One Financial assumed coverage on shares of MedEquities Realty Trust in a research report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price objective on the stock. Zacks Investment Research downgraded shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, ValuEngine upgraded shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research report on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. MedEquities Realty Trust presently has an average rating of “Buy” and a consensus price target of $13.00.

Shares of MedEquities Realty Trust (MRT) opened at $11.01 on Friday. The company has a market cap of $355.35, a price-to-earnings ratio of 27.53 and a beta of -0.74. MedEquities Realty Trust has a 52-week low of $10.06 and a 52-week high of $13.06.

In related news, CEO John W. Mcroberts purchased 18,000 shares of MedEquities Realty Trust stock in a transaction on Friday, November 17th. The shares were bought at an average cost of $10.74 per share, for a total transaction of $193,320.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Randy L. Churchey purchased 5,300 shares of MedEquities Realty Trust stock in a transaction on Monday, November 20th. The stock was bought at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the completion of the acquisition, the director now owns 46,776 shares in the company, valued at approximately $508,455.12. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 23,600 shares of company stock worth $254,129. 2.50% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System increased its holdings in MedEquities Realty Trust by 24.5% in the 2nd quarter. California State Teachers Retirement System now owns 50,800 shares of the financial services provider’s stock valued at $641,000 after acquiring an additional 10,000 shares during the last quarter. American Century Companies Inc. increased its holdings in MedEquities Realty Trust by 11.2% in the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock valued at $20,283,000 after acquiring an additional 174,261 shares during the last quarter. Prudential Financial Inc. increased its holdings in MedEquities Realty Trust by 5.4% in the 3rd quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock valued at $31,242,000 after acquiring an additional 136,499 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in MedEquities Realty Trust in the 3rd quarter valued at $411,000. Finally, Citadel Advisors LLC bought a new stake in MedEquities Realty Trust in the 3rd quarter valued at $312,000. Institutional investors own 93.19% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.watchlistnews.com/keycorp-research-analysts-boost-earnings-estimates-for-medequities-realty-trust-inc-mrt/1804112.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.